Advanced Biomed Inc. Common Stock (ADVB) vs Cerenome, Inc. (CNSY)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Cerenome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.74HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
CNSY
Cerenome, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 10:36 AM EDT
Total return — ADVB vs CNSY
growth of $100 · dividends reinvested · last 1yADVB +24.8% (+24.8%/yr)CNSY -61.5% (-61.5%/yr)ADVB compounded faster over this window
ADVB CNSY
ADVB vs CNSY: by the numbers
- •CNSY is the larger company ($11M vs $9M market cap).
- •Both run net losses; ADVB's is the smaller (0.00% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | ADVB | CNSY |
|---|---|---|
| P/S ratio | N/A | 2.57 |
| P/B ratio | 1.01 | 1.98 |
Profitability
| Metric | ADVB | CNSY |
|---|---|---|
| Gross margin | 0.00% | 89.58% |
| Operating margin | 0.00% | -293.46% |
| Net margin | 0.00% | -620.70% |
| ROE | -7.36% | -477.54% |
| ROIC | -11.06% | -479.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.